Parties d'ouvrages collectifs (1)
  1. 1. Hallin, M., Deplano, A., & Struelens, M. (2011). Molecular typing of bacterial pathogens: A tool for the epidemiological study and control of infectious diseases. In New Frontiers of Molecular Epidemiology of Infectious Diseases (pp. 9-25). Springer Netherlands. doi:10.1007/978-94-007-2114-2_2
    2.   Articles dans des revues avec comité de lecture (64)
  2. 1. Yin, N., Van den Wijngaert, S., Wautier, M., Martiny, D., Hallin, M., & Vandenberg, O. (2024). Surveillance of the respiratory syncytial virus outside infancy: impact of testing methods, a retrospective observational study. ERJ Open Research, 10(2), 00869-2023. doi:10.1183/23120541.00869-2023
  3. 2. Michel, C., Martin, C., Smeesters, P., Goffard, J.-C., Demuyser, T., & Hallin, M. (2023). Next-generation sequencing: what are the needs in routine clinical microbiology? A survey among clinicians involved in infectious diseases practice. Frontiers in Medicine, 10, 1225408. doi:10.3389/fmed.2023.1225408
  4. 3. Deplano, A., Hallin, M., Bustos Sierra, N., Michel, C., Prevost, B., Martiny, D., & Yin, N. (2023). Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium. Journal of antimicrobial chemotherapy. doi:10.1093/jac/dkad204
  5. 4. Zangarini, L., Martiny, D., Miendje Deyi, Y. V., Hites, M., Maillart, E., Hainaut, M., Delforge, M.-L., Botteaux, A., Matheeussen, V., Goossens, H., Hallin, M., Smeesters, P., & Dauby, N. (2023). Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005–2020. European journal of clinical microbiology & infectious diseases, 42(5), 555-567. doi:10.1007/s10096-023-04568-y
  6. 5. Yin, N., Van Nuffelen, M., Bartiaux, M., Preseau, T., Roggen, I., Delaunoy, S., Mahadeb, B., Dahma, H., Busson, L., Vandenberg, O., & Hallin, M. (2022). Clinical impact of the rapid molecular detection of RSV and influenza A and B viruses in the emergency department. PloS one, 17(9), e0274222. doi:10.1371/journal.pone.0274222
  7. 6. Baede, V. V., David, M. M., Andrasevic, A. T., Blanc, D., Borg, M., Brennan, G., Catry, B., Chabaud, A., Empel, J., Enger, H., Hallin, M., Ivanova, M., Kronenberg, A., Kuntaman, K., Larsen, A. A., Latour, K., Lindsay, J. A., Pichon, B. M., Santosaningsih, D., Schouls, L. L., Vandenesch, F., Werner, G., Żabicka, D., Zemlickova, H., Seifert, H., & Vos, M. M. (2022). MRSA surveillance programmes worldwide: moving towards a harmonised international approach. International journal of antimicrobial agents, 59(3), 106538. doi:10.1016/j.ijantimicag.2022.106538
  8. 7. Yin, N., Debuysschere, C., Daubie, V., Hildebrand, M., Martin, C., Curac, S., Ponthieux, F., Payen, M.-C., Vandenberg, O., & Hallin, M. (2022). Evaluation and Modelling of the Performance of an Automated SARS-CoV-2 Antigen Assay According to Sample Type, Target Population and Epidemic Trends. Diagnostics, 12(2), 447. doi:10.3390/diagnostics12020447
  9. 8. Cupaiolo, R., Cherkaoui, S., Serrano, G., Dauby, N., Georgala, A., Blumental, S., Maillart, E., Hites, M., Hallin, M., & Martiny, D. (2022). Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow. Journal of microbiological methods, 194, 106433. doi:10.1016/j.mimet.2022.106433
  10. 9. Yin, N., Dellicour, S., Daubie, V., Franco, N., Wautier, M., Faes, C., Van Cauteren, D., Nymark, L., Hens, N., Gilbert, M., Hallin, M., & Vandenberg, O. (2021). Leveraging of SARS-CoV-2 PCR Cycle Thresholds Values to Forecast COVID-19 Trends. Frontiers in medicine, 8. doi:10.3389/fmed.2021.743988
  11. 10. Argudín, M. Á. M., Deplano, A., Nonhoff, C., Yin, N., Michel, C., Martiny, D., De Keersmaecker, S. S., & Hallin, M. (2021). Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium. European journal of clinical microbiology & infectious diseases. doi:10.1007/s10096-021-04286-3
  12. 11. Montesinos Hernandez, I., Dahma, H., Wolff, F., Dauby, N., Delaunoy, S., Wuyts, M., Detemmerman, C., Duterme, C., Vandenberg, O., Martin, C., & Hallin, M. (2021). Neutralizing antibody responses following natural SARS-CoV-2 infection: dynamics and correlation with commercial serologic tests. Journal of clinical virology, 104988. doi:10.1016/j.jcv.2021.104988
    13. << Précédent 1 2 3 4 5 6 Suivant >>